Table 1.
N (%) | ||
---|---|---|
Male | 15/26 (58%) | |
No. Caucasian (%); African American (%) | 24/26 (92%); 2/26 (8%) | |
Median Age (Range) | 65 (19–81) | |
Median Overall Survival | 3.6 months | |
Median Lines of Prior Therapy (Range) | 3 (1–9) | |
Diagnosis | ||
Acute Myeloid Leukemia | 11 (42%) | |
Non-Hodgkin's Lymphoma | 6 (22%) | |
Multiple Myeloma | 4 (16%) | |
Myelodysplastic Syndrome | 4 (16%) | |
Hodgkin’s Lymphoma | 1 (4%) |